CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 27 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 17 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 17 | -98.2% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 936 | -52.2% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,960 | -93.6% | 0.00% | – |
| Q3 2022 | $44,000 | +29.4% | 30,460 | -3.5% | 0.00% | – |
| Q2 2022 | $34,000 | +325.0% | 31,549 | +1000.4% | 0.00% | – |
| Q1 2022 | $8,000 | -75.0% | 2,867 | -65.7% | 0.00% | – |
| Q4 2021 | $32,000 | – | 8,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |